|
IKBKAP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66533453693773E-15 |
| Normal-vs-Stage2 |
1.20290000182877E-08 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.6494583476856E-12 |
| Stage1-vs-Stage2 |
7.308400E-01 |
| Stage1-vs-Stage3 |
9.340300E-02 |
| Stage1-vs-Stage4 |
1.990040E-02 |
| Stage2-vs-Stage3 |
1.489960E-01 |
| Stage2-vs-Stage4 |
4.653600E-02 |
| Stage3-vs-Stage4 |
3.082000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.84232000000062E-05 |
| Normal-vs-Asian |
5.95369999967232E-08 |
| Caucasian-vs-AfricanAmerican |
1.102630E-01 |
| Caucasian-vs-Asian |
2.339800E-02 |
| AfricanAmerican-vs-Asian |
9.403400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62525548574877E-12 |
| Male-vs-Female |
5.524200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62991842245219E-12 |
| Normal-vs-Age(41-60Yrs) |
4.39648317751562E-14 |
| Normal-vs-Age(61-80Yrs) |
1.62747593179802E-12 |
| Normal-vs-Age(81-100Yrs) |
1.03559999997671E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.022400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.493900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.174620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.528400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.169800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.959800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.235600E-03 |
| Classical-VS-Follicular |
7.067200E-01 |
| Classical-VS-Other |
3.333600E-01 |
| Classical-VS-Normal |
1.62492241884138E-12 |
| Tall-VS-Follicular |
2.128200E-02 |
| Tall-VS-Other |
6.644200E-01 |
| Tall-VS-Normal |
1.70641278884887E-12 |
| Follicular-VS-Other |
4.858600E-01 |
| Follicular-VS-Normal |
8.48330294900279E-11 |
| Other-VS-Normal |
3.71110000000341E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.44169137633799E-14 |
| Normal-vs-N1 |
3.2085445411667E-14 |
| N0-vs-N1 |
6.556300E-02 |
|
|
